SCHEMBL4768751

SCHEMBL4768751

c1ccc(-c2nc(NC[C@@H]3CCCN3)cc(-c3cccnc3)n2)nc1

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
IRAK4 Q9NWZ3 1/20 0.46
CYP3A4 P08684 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2A6 P11509 1/20 0.42
CCNT1 O60563 2/20 0.41
SLC2A1 P11166 1/20 0.41
GPR39 O43194 3/20 0.40
TGFBR1 P36897 1/20 0.40
TGFBR2 P37173 1/20 0.40
NPC1 O15118 1/20 0.40
TP53 P04637 1/20 0.40
PKM P14618 1/20 0.40
TSHR P16473 1/20 0.40
RAB9A P51151 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
VCP P55072 2/20 0.40
ACP1 P24666 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4773121 0.79 GPR39 (0.46) CYP3A4CYP2C9CYP2A6SLC2A1GPR39
SCHEMBL2238098 0.76 PTGDR (0.53) CYP3A4CYP2C9CYP2A6SLC2A1NPC1
SCHEMBL2239929 0.76 CYP3A4 (0.65) CYP3A4CYP2C9CYP2A6SLC2A1GPR39
SCHEMBL4771527 0.76 CYP3A4 (0.55) CYP3A4CYP2C9CYP2A6SLC2A1NPC1
SCHEMBL4775842 0.76 CYP3A4 (0.60) CYP3A4CYP2C9CYP2A6SLC2A1TSHR
SCHEMBL4768766 0.76 CYP2A6 (0.46) CYP2A6NPC1TP53PKMTSHR
SCHEMBL4769045 0.75 HDAC1 (0.48) CYP3A4CYP2C9CYP2A6SLC2A1ACP1
SCHEMBL4775067 0.75 CYP3A4 (0.57) CYP3A4CYP2C9CYP2A6SLC2A1GPR39
SCHEMBL2238265 0.74 CYP3A4 (0.45) CYP3A4CYP2C9CYP2A6SLC2A1TGFBR1
SCHEMBL2240945 0.74 GBA1 (0.54) CYP3A4CYP2C9CYP2A6SLC2A1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1878733-A1 Pyrimidine derivatives as ALK-5 inhibitors Novartis AG (CH) 2008-01-16 EP disclosed